INTACS (Intrastromal Corneal Ring Segments) For Corneal Ectasia
Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jul 29, 2015
Trial Information
Current as of May 03, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The INTACS trial is studying a surgical treatment called INTACS, which involves placing special ring segments in the eye to help improve vision for people with a condition called keratoconus. This condition causes the cornea, the clear front part of the eye, to become thin and misshapen, leading to blurry vision that cannot be corrected with glasses or contact lenses. The trial aims to see how well these ring segments work in reducing vision problems like myopia (nearsightedness) and astigmatism in patients who have experienced worsening vision and have few options left.
To participate in this trial, you must be at least 21 years old and have noticed a steady decline in your vision to the point where glasses or contact lenses no longer help. You also need to have clear central corneas and enough thickness in your corneas for the surgery. If you qualify, you can expect to undergo a surgical procedure to implant the INTACS segments, which may help improve your vision. It’s important to note that this trial is not yet recruiting participants, so you will need to wait for it to start before applying.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 21 years of age, or older
- • have experienced a progressive deterioration in their vision, such that they can no longer achieve adequate functional vision on a daily basis with contact lenses, or spectacles.
- • have clear central corneas
- • have a corneal thickness of 450 microns or greater at the proposed incision site
- • have corneal transplantation as the only remaining option to improve their visual function
- Exclusion Criteria:
- • under 21 years of age
- • have not experienced a progressive deterioration in their vision, such that they can no longer achieve adequate functional vision on a daily basis with contact lenses, or spectacles.
- • do not have clear central corneas
- • do not have a corneal thickness of 450 microns or greater at the proposed incision site
- • do not have corneal transplantation as the only remaining option to improve their visual function
About University Of California, San Diego
The University of California, San Diego (UCSD) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust focus on translational medicine, UCSD leverages its interdisciplinary approach to explore groundbreaking therapies and interventions across a wide range of medical fields. The university's state-of-the-art facilities and collaboration with top-tier faculty and researchers ensure a comprehensive and ethical framework for conducting clinical trials, ultimately aiming to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Christopher Heichel, MD
Principal Investigator
University of California, San Diego, Shiley Eye Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials